John Roehrig died March 8 after a battle with ALS. During his career, he was on the front lines of the U.S. response to West Nile virus.

Ottawa, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The global viral vector and plasmid DNA manufacturing market size was valued at USD 7.19 billion in 2024 and is expected to be worth around USD 46.02 ...

In a potentially major breakthrough for regenerative medicine, scientists at MIT have developed a way to convert skin cells ...

The global viral vectors for non-human primates market was valued at USD 145.8 Mn in 2023 and is projected to grow at a CAGR ...

The global viral vector and plasmid DNA manufacturing market size was calculated at US$ 7.26 billion in 2024 and is projected to reach around US$ 43.04 billion by 2034, expanding at a compound annual ...

Sesame, the AI startup behind the impressively realistic voice assistant Maya, has released the base AI model powering Maya.

Dengue virus, a WHO grade 3 emergency, infected over 10 million individuals in 2024. With no population-effective prophylaxis or direct treatment, there is an urgent need for immediate vector control ...

That therapy uses an adeno-associated virus (AAV) as a vector rather than a lentivirus, a vector type that features in approved gene therapies such as Roche's Luxturna and Novartis' Zolgensma.

Yet, the complexity of scaling viral vector processes to commercial levels and the absence of standardized approaches pose significant challenges for therapy development timelines and productivity.

New York is testing its milk for bird flu. While pasteurization kills the virus, there is a growing concern raw milk could be ...

Strasbourg (France), March 11, 2025, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today ...

Converting one type of cell to another—for example, a skin cell to a neuron—can be done through a process that requires the ...